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Background
Sensitive/less-sensitive (S/LS) serologic assays that differ-
entiate recent from established HIV infection may not be
suitable for use in resource-limited and financially chal-
lenged countries. A more simple and affordable method is
needed to address these limitations. Methods: The Serodia
HIV-1/HIV-2 particle agglutination assay (PA) was modi-
fied to act as a S/LS assay. Antigen-coated gelatin particles
were diluted 1:68, and sera were diluted at intervals from
1:10 to 1:80,000; HIV antibody status was confirmed at
the 1:10 dilution. 37 clade B seroconversion panels from
Trinidad and BBI (n = 309) were tested at each sample
dilution to calibrate the PA assay; the last positive reaction
(>1+) was considered the endpoint dilution (ED). The
greatest sensitivity for correctly classifying recent and
established infection samples was determined by ROC
analyses. A subset of these panels (n = 181) was also tested
by the Vironostika S/LS (DV) as a reference for compari-
son.
Results
At a dilution of 1:40,000 and a days post SC cutoff of 190
days the PA test gave 97% sensitivity for classifying both
recent and established infection samples, as compared
with 82% and 53% on a subset tested by the DV; this
resulted in a poor concordance of 60% and 73%.
Conclusion
A low cost, simple to perform PA test was modified as a S/
LS test and exhibited excellence in distinguishing recent
and established HIV infection. The PA S/LS performed
more accurately than the reference DV S/LS when testing
samples with known times of seroconversion.
from 2005 International Meeting of The Institute of Human Virology
Baltimore, USA, 29 August – 2 September 2005
Published: 8 December 2005
Retrovirology 2005, 2(Suppl 1):P41 doi:10.1186/1742-4690-2-S1-P41
<supplement> <title> <p>2005 International Meeting of The Institute of Human Virology</p> </title> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available here. [link 'here' using 'a href' to: <url>http://www.biomedcentral.com/content/pdf/1742-4690-2-S1-full. df</url>]</not /supplement>
